A new study out of UCSF found that nearly 100% of patients who took the abortion pill through telemedicine suffered no adverse events afterwards as the Supreme Court decides if access should be further limited.
The abortion industry is planning its next scheme to expand abortion pill access by suggesting pharmacists can prescribe the abortion pill, mifepristone. The move comes a year after the FDA gutted its REMS safety system for the abortion pill by announcing it would allow retail pharmacies to dispense the drug.
Health and Human Services Secretary Xavier Becerra arrived at UCSF on a fact-finding mission Monday, meeting with OBGYN doctors and professors to discuss front-line stories of how abortion care has changed since the Supreme Court's decision that overturned Roe vs. Wade opened to door for some states to adopt abortion restrictions.